Thyroid Cancer Database

July 23, 2019 updated by: Centre Georges Francois Leclerc

Prospective and Retrospective Thyroid Cancer Database

Thyroid cancer database collects clinical and laboratory data from patients with a thyroid tumor who received radioactive Iodine treatment. This database only records information based on patients' medical files in a structured manner.

Thyroid database is used for retrospective non-interventional research projects.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

2300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: AURELIE BERTAUT, MD, PhD
  • Phone Number: +33 3 80 73 77 84
  • Email: ABertaut@cgfl.fr

Study Locations

  • France
      • Dijon, France
        • Recruiting
        • Methodology, Biostatistics and Data Management
        • Contact:
          • AURELIE BERTAUT, MD, PhD
          • Phone Number: +33 3 80 73 77 84

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with a thyroid tumor who received radioactive Iodine treatment in Centre Georges Francois Leclerc, Dijon, France

Description

Inclusion Criteria:

  • patients with a thyroid tumor (metastatic or not)
  • patients who received radioactive Iodine treatment.
  • age >= 18

Exclusion Criteria:

  • Objection to collect medical data records

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Radioactive Iodine treatment for thyroid cancer
Other: Radioactive Iodine treatment
Patients with a thyroid tumor who received radioactive Iodine treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient survival
Time Frame: 10 years
Overall survival and evolution over years
10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Collection of patient and treatment characteristics
Time Frame: 10 years
Collection of patient and treatment characteristics over years, to set up prospective and retrospective studies
10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Georges Francois Leclerc

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2000

Primary Completion (Anticipated)

January 1, 2025

Study Completion (Anticipated)

January 1, 2025

Study Registration Dates

First Submitted

July 1, 2019

First Submitted That Met QC Criteria

July 23, 2019

First Posted (Actual)

July 24, 2019

Study Record Updates

Last Update Posted (Actual)

July 24, 2019

Last Update Submitted That Met QC Criteria

July 23, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AB2015THYROID

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patients With a Thyroid Tumor Who Received Radioactive Iodine Treatment

Clinical Trials on Radioactive Iodine treatment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe